SCIENTIFIC BACKGROUND

MVK

Mevalonate aciduria (MA) and hyper-IgD-and-periodic fever syndrome (HIDS) represent the two ends of the spectrum of clinical symptoms of mevalonate kinase deficiency (MKD). The severity of symptoms depends on the remaining enzyme activity of mevalonate kinase; in HIDS it is approximately 10%, in MA <0.5%.

 

HIDS is one of the rare congenital periodic fever syndromes: a few hundred cases of HIDS are thought to occur worldwide. The disease is inherited in an autosomal recessive manner and almost invariably manifests in early childhood, usually in the first year of life. Febrile episodes usually occur every 4–8 weeks and last approximately 3–7 days. In up to 50% of cases, the episodes have certain triggers, usually vaccinations, stress, and infections. The relapses are typically accompanied by cervical lymphadenopathy, arthritis/arthralgias, measles-like exanthema, and abdominal pain with diarrhea and vomiting. Usually, the specific symptoms are preceded by marked headache and chills. The development of amyloidosis is very rare. There is usually a continuous elevation of IgD (and IgA) serum concentrations above 100 IU/ml, but in about 20% of cases, especially in young children, IgD levels may be within normal limits. There are currently no accepted guidelines for the treatment of HIDS. In addition to non-steroidal anti-inflammatory drugs, corticosteroids are initially used during febrile episodes. In severe cases, treatment with IL1 blockers seems to be promising.

 

Symptoms of MA include psychomotor retardation, failure to thrive, progressive cerebellar ataxia, dysmorphia, progressive loss of vision, and recurrent fevers. Life expectancy is often limited.

 

Both diseases are caused by mutations in the MVK gene, which encodes mevalonate kinase, a key enzyme in cholesterol biosynthesis. The relationship between a defect in cholesterol biosynthesis and an autoinflammatory disease pattern is still unclear. In about 80% of HIDS patients, the mutation V377I in exon 11 is present in homozygous form or in combination with a second mutation.

 

References
Gattorno et al. 2019, Ann Rheum Dis 78:1025 / Martorana et al. 2017, Front Immunol 8:344 / van der Burgh et al. 2013, Clin Immunol 147:197 / Mandey et al. 2006, Hum Mut 27:796

GENES

MVK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more